The current role of 18F-FDOPA PET for neuroendocrine tumor imaging - ScienceDirect
18F-AlF-NOTA-octreotide PET/CT in the Detection of Culprit Tumor Causing Tumor-Induced Osteomalacia | Journal of Nuclear Medicine
DNA Marker
High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling | Cell Death & Disease
Dolznig Lab | MedUni Vienna
Biomarkers in Alzheimer's disease
Uzlinový syndrom - Zdraví.euro.cz
Rozdíly mezi jednotlivými lymfodrenážními přístroji z hlediska účinnosti procedury - BS Systems s.r.o.
Effect of CD133 overexpression on bone metastasis in prostate cancer cell line LNCaP
![18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-020-04918-4/MediaObjects/259_2020_4918_Fig1_HTML.png "18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink")
18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink
Immunopositivity for lymphatic endothelial marker D2-40 (podoplanin) in... | Download Scientific Diagram
Zvětšení (zduření) lymfatických uzlin (lymfadenopatie) - příznaky, příčiny a léčba | Rehabilitace.info
CAS 26780-50-7 | Sigma-Aldrich
Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures - Falgàs - 2020 - Human Brain Mapping - Wiley Online Library
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
Design, synthesis, and biological evaluation of small molecule PROTACs for potential anticancer effects | SpringerLink
Head-to-head Comparison of the 18F-AlF-NOTA-Octreotide and 68Ga-DOTATATE PET/CT within patients with Neuroendocrine Neoplasms | Journal of Nuclear Medicine
Uzlinový syndrom – diferenciální diagnostika - Zdraví.euro.cz
Evaluation of D-isomers of 4-borono-2-18F-fluoro-phenylalanine and O-11C-methyl-tyrosine as brain tumor imaging agents: a comparative PET study with their L-isomers in rat brain glioma | EJNMMI Research | Full Text
Uzlinový syndrom - Zdraví.euro.cz
LYMFATICKÉ UZLINY - CelostniMedicina.cz
![Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-021-05351-x/MediaObjects/259_2021_5351_Fig6_HTML.png "Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours | SpringerLink")
Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours | SpringerLink
Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay
![18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-020-04918-4/MediaObjects/259_2020_4918_Fig6_HTML.png "18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink")
18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
![Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment](https://www.frontiersin.org/files/Articles/528772/fneur-11-00754-HTML/image_m/fneur-11-00754-g001.jpg "Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment")